The successful raise of $125 million through warrant distribution is a significant financial milestone for Cassava Sciences, indicating investor confidence and providing the company with additional resources to fund its operations and research projects. This influx of capital is likely to be viewed positively by the market, potentially leading to a short-term increase in the stock price as it directly impacts the company's financial stability and future growth prospects.